Application Notes

Cellastim S – Reconstitution Application Note

AAV Production – How To Improve Transfection Efficiency and Titer Yield

Blog

Controlling Impurities in Cell Culture Media

Explore the Latest Developments in T-reg Research and Clinical Application

Exploring the Latest Research and Opportunities in T-reg Therapy

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

SARS-CoV2 and Influenza – Double Threat

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Blood-Free Fetal Bovine Serum Alternatives in Cell Culture Media

Revolutionizing Cell Immunotherapies with Serum Free T Cell Media

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Product Brochures

2021 Product Catalog

Optiferrin – Product Brochure

Product Specifications

Cellastim S – Product Specifications

SDS

Optibumin – Safety Data Sheet

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Optiferrin – Guidelines for Use

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Optiferrin – Recombinant Transferrin an Iron Transport Protein in Cell Culture Media

Optimization of Albumin Inclusion in Cell Culture Media – Fatty Acid Profiles